BACKGROUND: Despite increasing attention on reducing relatively costly hospital practices while maintaining the quality of care, few studies have examined how hospitals use the intensive care unit (ICU), a high-cost setting, for patients admitted with heart failure (HF). We characterized hospital patterns of ICU admission for patients with HF and determined their association with the use of ICU-level therapies and patient outcomes. METHODS AND RESULTS: We identified 166 224 HF discharges from 341 hospitals in the 2009-2010 Premier Perspective database. We excluded hospitals with <25 HF admissions, patients <18 years old, and transfers. We defined ICU as including medical ICU, coronary ICU, and surgical ICU. We calculated the percent of patients admitted directly to an ICU. We compared hospitals in the top quartile (high ICU admission) with the remaining quartiles. The median percentage of ICU admission was 10% (interquartile range, 6%-16%; range, 0%-88%). In top-quartile hospitals, treatments requiring an ICU were used less often; the percentage of ICU days receiving mechanical ventilation was 6% for the top quartile versus 15% for the others; noninvasive positive pressure ventilation, 8% versus 19%; vasopressors and/or inotropes, 9% versus 16%; vasodilators, 6% versus 12%; and any of these interventions, 26% versus 51%. Overall HF in-hospital risk-standardized mortality was similar (3.4% versus 3.5%; P=0.2). CONCLUSIONS:ICU admission rates for HF varied markedly across hospitals and lacked association with in-hospital risk-standardized mortality. Greater ICU use correlated with fewer patients receiving ICU interventions. Judicious ICU use could reduce resource consumption without diminishing patient outcomes.
RCT Entities:
BACKGROUND: Despite increasing attention on reducing relatively costly hospital practices while maintaining the quality of care, few studies have examined how hospitals use the intensive care unit (ICU), a high-cost setting, for patients admitted with heart failure (HF). We characterized hospital patterns of ICU admission for patients with HF and determined their association with the use of ICU-level therapies and patient outcomes. METHODS AND RESULTS: We identified 166 224 HF discharges from 341 hospitals in the 2009-2010 Premier Perspective database. We excluded hospitals with <25 HF admissions, patients <18 years old, and transfers. We defined ICU as including medical ICU, coronary ICU, and surgical ICU. We calculated the percent of patients admitted directly to an ICU. We compared hospitals in the top quartile (high ICU admission) with the remaining quartiles. The median percentage of ICU admission was 10% (interquartile range, 6%-16%; range, 0%-88%). In top-quartile hospitals, treatments requiring an ICU were used less often; the percentage of ICU days receiving mechanical ventilation was 6% for the top quartile versus 15% for the others; noninvasive positive pressure ventilation, 8% versus 19%; vasopressors and/or inotropes, 9% versus 16%; vasodilators, 6% versus 12%; and any of these interventions, 26% versus 51%. Overall HF in-hospital risk-standardized mortality was similar (3.4% versus 3.5%; P=0.2). CONCLUSIONS: ICU admission rates for HF varied markedly across hospitals and lacked association with in-hospital risk-standardized mortality. Greater ICU use correlated with fewer patients receiving ICU interventions. Judicious ICU use could reduce resource consumption without diminishing patient outcomes.
Authors: Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz Journal: Pharmacoepidemiol Drug Saf Date: 2012-01 Impact factor: 2.890
Authors: Harlan M Krumholz; Zhenqiu Lin; Elizabeth E Drye; Mayur M Desai; Lein F Han; Michael T Rapp; Jennifer A Mattera; Sharon-Lise T Normand Journal: Circ Cardiovasc Qual Outcomes Date: 2011-03
Authors: Dale W Bratzler; Sharon-Lise T Normand; Yun Wang; Walter J O'Donnell; Mark Metersky; Lein F Han; Michael T Rapp; Harlan M Krumholz Journal: PLoS One Date: 2011-04-12 Impact factor: 3.240
Authors: Vivek T Kulkarni; Nancy Kim; Ying Dai; Kumar Dharmarajan; Kyan C Safavi; Behnood Bikdeli; Peter K Lindenauer; Jeffrey Testani; Daniel L Dries; Harlan M Krumholz Journal: Circ Heart Fail Date: 2014-03-14 Impact factor: 8.790
Authors: Xiao Xu; Shu-Xia Li; Haiqun Lin; Sharon-Lise T Normand; Nancy Kim; Lesli S Ott; Tara Lagu; Michael Duan; Eugene A Kroch; Harlan M Krumholz Journal: Health Serv Res Date: 2014-06-28 Impact factor: 3.402
Authors: Thomas S Valley; Brahmajee K Nallamothu; Michael Heung; Theodore J Iwashyna; Colin R Cooke Journal: Crit Care Med Date: 2018-02 Impact factor: 7.598
Authors: Allan J Walkey; Emily K Quinn; Michael R Winter; David D McManus; Emelia J Benjamin Journal: JAMA Cardiol Date: 2016-09-01 Impact factor: 14.676
Authors: Thomas S Valley; Michael W Sjoding; Andrew M Ryan; Theodore J Iwashyna; Colin R Cooke Journal: JAMA Date: 2015 Sep 22-29 Impact factor: 56.272
Authors: Meng-Yun Lin; Nancy R Kressin; Michael K Paasche-Orlow; Eun Ji Kim; Lenny López; Jennifer E Rosen; Amresh D Hanchate Journal: Med Care Date: 2018-08 Impact factor: 2.983
Authors: Michael W Sjoding; Hallie C Prescott; Hannah Wunsch; Theodore J Iwashyna; Colin R Cooke Journal: Crit Care Med Date: 2015-06 Impact factor: 7.598
Authors: Elinore J Kaufman; Douglas J Wiebe; Niels D Martin; Jose L Pascual; Patrick M Reilly; Daniel N Holena Journal: J Surg Res Date: 2016-03-30 Impact factor: 2.192